Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filings

Filing date Description Form Filing Group View

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Registration of up to an additional 20% of securities for any offering registered on an S-1

S-1MEF
Registration Statements
View HTML

Copyright Morningstar